Showing results (91-100 of 182) with videos related to
Sort By:
Pageof 19
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 18, 2014
Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, IndonesiaAzzania Fibriani, Rudi Wisaksana, Bachti Alisjahbana, et al.International Journal of Biometeorology|November 25, 2024
Mapping tree canopy thermal refugia for birds using biophysical models and LiDARLara H Strydom, Shannon R Conradie, Izak P J Smit, et al.Metabolism: Clinical and Experimental|June 28, 2015
Dietary habits and leisure-time physical activity in relation to adiposity, dyslipidemia, and incident dysglycemia in the pathobiology of prediabetes in a biracial cohort studyAndrew B Boucher, E A Omoluyi Adesanya, Ibiye Owei, et al.Journal of Virological Methods|December 22, 2005
A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variantsN M van Maarseveen, M C D G Huigen, D de Jong, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumorsS N Holden, S G Eckhardt, R Basser, et al.Physical Chemistry Chemical Physics : PCCP|June 25, 2013
Single atom alloy surface analogs in Pd0.18Cu15 nanoparticles for selective hydrogenation reactionsMatthew B Boucher, Branko Zugic, George Cladaras, et al.Journal of Virological Methods|July 7, 2012
Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: improvement and implementationAzzania Fibriani, Nadya Farah, Inri Kusumadewi, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 20, 2011
A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis BMilan J Sonneveld, Vincent Rijckborst, Charles A B Boucher, et al.The Lancet. Infectious Diseases|September 27, 2016
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling studyBrooke E Nichols, Charles A B Boucher, Marc van der Valk, et al.Retrovirology|April 3, 2012
Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacityNoortje M van Maarseveen, Dan Andersson, Martin Lepšík, et al.Pageof 19